CNBX PHARMACEUTICALS INC. (CNBX) Net margin 2016–2024
CNBX PHARMACEUTICALS INC. (CNBX) net profit margin by fiscal year — reported net income divided by reported revenue.
-534.5%FY2024 · since FY2016: -273.0% → -534.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -534.5% | +370.1 pp |
| FY2023 | -904.6% | +11523.7 pp |
| FY2022 | -12428.2% | — |
| FY2020 | -104337.9% | -115848.3 pp |
| FY2019 | 11510.4% | +50846.1 pp |
| FY2018 | -39335.7% | -5313.1 pp |
| FY2017 | -34022.5% | -33749.5 pp |
| FY2016 | -273.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CNBX financial trends
CNBX RevenueCNBX Net incomeCNBX Gross profitCNBX Gross marginCNBX Operating incomeCNBX Operating marginCNBX Operating cash flowCNBX Free cash flowCNBX Capital expendituresCNBX Return on equityCNBX Stock buybacksCNBX Dividends paidCNBX Total assetsCNBX Total liabilitiesCNBX Shareholders’ equityCNBX overview →